Evidence map›Paper›PMID 31742587›Full record

Trial reportBlood2019

Beneficial effects of endurance exercise training on skeletal muscle microvasculature in sickle cell disease patients.

Angèle N Merlet, Laurent A Messonnier, Cécile Coudy-Gandilhon, Daniel Béchet, Barnabas Gellen, Thomas Rupp, Frédéric Galactéros, Pablo Bartolucci, Léonard Féasson

2 registry-linked trialsAbstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Blood, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02571088 nacompletednot on this map

Evaluation of a Training Program for Homozygous Sickle Cell Disease Patients: Benefits on Physical Ability and Skeletal Muscle. An Interventional Pilot, Multicentric, Prospective, Longitudinal Study

TypeinterventionalSponsorCentre Hospitalier Universitaire de Saint EtienneRan2014 to 2016Enrolled40ConditionsSickle Cell Hemoglobin C Disease, Hemoglobin S DiseaseArmsTraining Program
NCT05714098 nacompletednot on this mapstarted 2023, after this paper: background citation

Gerofit Exercise Intervention for Older Adults With Sickle Cell Disease (SICKLE-FIT Study)

TypeinterventionalSponsorDuke UniversityRan2023 to 2025Enrolled33ConditionsSickle Cell DiseaseArmsGerofit Exercise Program
3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Skeletal Muscle Satellite Cells in Sickle Cell Disease Patients and Their Responses to a Moderate-intensity Endurance Exercise Training Program.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Angèle N MerletLaboratoire Interuniversitaire de Biologie de la Motricité, Université de Lyon, Université Jean Monnet, Saint-Etienne, France.
Laurent A MessonnierLaboratoire Interuniversitaire de Biologie de la Motricité, Université Savoie Mont Blanc, Chambéry, France.
Cécile Coudy-GandilhonInstitut National de la Recherche Agronomique, Unité de Nutrition Humaine, Saint Genès Champanelle, France.
Daniel BéchetInstitut National de la Recherche Agronomique, Unité de Nutrition Humaine, Saint Genès Champanelle, France.
Barnabas GellenService de Réhabilitation Cardiaque, Hôpital Henri-Mondor (Assistance Publique-Hôpitaux de Paris [APHP]), Créteil, France.
Thomas RuppLaboratoire Interuniversitaire de Biologie de la Motricité, Université Savoie Mont Blanc, Chambéry, France.
Frédéric GalactérosService de Médecine Interne, Hôpital Henri-Mondor (AP-HP), Université Paris-Est Créteil (UPEC), Créteil, France.
Pablo BartolucciService de Médecine Interne, Hôpital Henri-Mondor (AP-HP), Université Paris-Est Créteil (UPEC), Créteil, France.
Léonard FéassonLaboratoire Interuniversitaire de Biologie de la Motricité, Université de Lyon, Université Jean Monnet, Saint-Etienne, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sickle cell disease (SCD) is a genetic hemoglobinopathy leading to 2 major clinical manifestations: severe chronic hemolytic anemia and iterative vaso-occlusive crises. SCD is also accompanied by profound muscle microvascular remodeling. The beneficial effects of endurance training on microvasculature are widely known. The aim of this study was to evaluate the effects of an endurance training program on microvasculature of skeletal muscle in SCD patients. A biopsy of the vastus lateralis muscle and submaximal incremental exercise was performed before and after the training period. Of the 40 randomized SCD patients, complete data sets from 32 patients were obtained. The training group (n = 15) followed a personalized moderate-intensity endurance training program, while the nontraining (n = 17) group maintained a normal lifestyle. Training consisted of three 40-minute cycle ergometer exercise sessions per week for 8 weeks. Histological analysis highlighted microvascular benefits in the training SCD patients compared with nontraining patients, including increases in capillary density (P = .003), number of capillaries around a fiber (P = .015), and functional exchange surface (P < .0001). Conversely, no significant between-group difference was found in the morphology of capillaries. Indexes of physical ability also improved in the training patients. The moderate-intensity endurance exercise training program improved the muscle capillary network and partly reversed the microvascular defects commonly observed in skeletal muscle of SCD patients. This trial was registered at www.clinicaltrials.gov as #NCT02571088.

Indexed as

Anemia, Sickle CellEndurance TrainingExercise TherapyMuscle, SkeletalAdultFemaleHumansMaleMicrovessels

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.